C9 and COVID-19: In accordance with Lamerton et al. [37], we observed that patients presenting antibodies able to induce C9-deposition in the milk belonged to the COVID-19 recovered group (#18 and #19) and, surprisingly, to the AstraZeneca-vaccinated group (#4, #21, and #22).